Session Chair Profile
Ph.D., Chief Scientific Officer and Co-Founder, Veritas Genetics
Biography
Dr. Estep is a genome scientist, and co-founder and adviser to many startup companies and non-profit organizations. He is Director of Gerontology and manages genome sequencing for the Personal Genome Project at Harvard Medical School. He is a Founding Adviser to Nebula Genomics, is an adviser to doc.ai, and was an adviser to Curoverse, a pioneering creator of open-source software, genome processing pipelines, and big data machine learning tools. Dr. Estep is a member of the Global Council on Brain Health, a group of scientific experts assembled by AARP and AGE-UK. The GCBH serves the 50 million members of AARP and AGE-UK. He is the author of The Mindspan Diet, published in 2016 by Ballantine Books/Random House Publishing. The Mindspan Diet is a synthesis of information from many fields of science, and summarizes the best evidence for the nutritional keys to extremes of human physical and mental longevity.
Genomic Profiling Showcase: Veritas Genetics
Veritas Genetics is a global leader in whole genome sequencing and reporting of key findings in health risks, traits, pharmacogenomics, and ancestry.
The Present And Future Of Whole Genome Sequencing
Whole genome sequencing is transforming research, and is poised to revolutionize routine health care, as it moves into the clinic and becomes part of a new foundation for prevention. Dr. Estep will present key obstacles and solutions to this important transition.
Session Abstract – PMWC 2019 Silicon Valley
The PMWC 2019 Genomic Profiling Showcase will take place on January 21, this showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
Confirmed Presenting Companies:
The PMWC 2019 Genomic Profiling Showcase will take place on January 21, this showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.
Confirmed Presenting Companies:
